Watchlist Price Alert

Calidi Biotherapeutics In... (CLDI)

AMEX: CLDI · Real-Time Price · USD

0.45

0.04 (8.43%)

At close: May 09, 2025, 3:59 PM

0.46

1.19%

After-hours: May 09, 2025, 05:05 PM EDT

Calidi Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	9.59M	1.9M	836K	1.24M	2.05M	10.25M	669.87K	82.83K	93.89K	39.94K	328.84K	597.52K	1.06M	1.2M	95K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	175K	230K	1.41M	43.21M	42.91M	42.45M	41.68M	230.18M	230.02M	230M	230M	n/a
Other Long-Term Assets	152K	217K	227K	331K	143K	30K	-5.73M	-6.01M	-1.09M	-1.01M	77.03K	178.99K	280.94K	n/a	507.38K
Receivables	n/a	n/a	181K	n/a	1.36M	n/a	870.00	870.00	870.00	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	249K	216K	206K	244K	125K	100K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	10.23M	2.22M	1.63M	1.94M	4.3M	11.69M	795.48K	268.86K	401.67K	479.09K	759.67K	1.03M	1.48M	2M	117.5K
Property-Plant & Equipment	3.8M	4.22M	4.58M	4.96M	5.34M	5.46M	5.73M	6.01M	1.09M	1.01M	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.96M	4.44M	4.81M	5.47M	5.72M	6.9M	43.21M	42.91M	42.45M	41.68M	230.26M	230.2M	230.29M	230M	507.38K
Total Assets	14.18M	6.66M	6.43M	7.41M	10.02M	18.59M	44.01M	43.18M	42.85M	42.16M	231.02M	231.24M	231.77M	232.01M	624.88K
Account Payables	2.07M	3.57M	4.55M	3.9M	2.88M	1.49M	677K	2.54M	2.27M	2.26M	n/a	n/a	624K	n/a	n/a
Deferred Revenue	n/a	n/a	2.46M	n/a	n/a	n/a	-677K	-2.54M	n/a	-2.26M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	3.18M	3.09M	2.98M	4.24M	807K	3.35M	1.49M	1.46M	5.42M	4.05M	n/a	n/a	5M	n/a	188.8K
Other Current Liabilities	1.63M	2M	2.66M	100K	n/a	200K	-1.71M	-4.27M	-8.62M	-10.17M	373.66K	386.83K	-8.86M	47.9K	52.8K
Total Current Liabilities	9.5M	11.58M	13.05M	14.95M	10.23M	10.87M	8.18M	6.62M	4.54M	1.34M	373.66K	386.83K	410.99K	47.9K	683.18K
Long-Term Debt	600K	2.37M	1.93M	3.38M	2.06M	1.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	128K	176K	565K	697K	2.71M	3.46M	926.6K	-2.39M	624.23K	8.82M	9.71M	14.07M	16M	20.93M	n/a
Total Long-Term Liabilities	2.72M	4.88M	5.13M	7.03M	8.02M	8.81M	4.58M	1.54M	1.07M	9.03M	9.71M	14.07M	16.04M	20.93M	n/a
Total Liabilities	12.21M	16.45M	18.18M	21.98M	18.25M	19.68M	12.77M	8.15M	5.61M	10.37M	10.08M	14.45M	16.45M	20.98M	683.18K
Total Debt	7.04M	9.02M	8.73M	11.71M	7.24M	9.75M	1.49M	1.46M	1.22M	460K	n/a	n/a	n/a	n/a	188.8K
Common Stock	2K	1K	1K	4K	4K	4K	43.21M	42.91M	42.45M	41.68M	230.18M	230.02M	230.01M	230M	575.00
Retained Earnings	-121.72M	-117.62M	-112.56M	-106.8M	-99.57M	-91.34M	-12.15M	-7.88M	-5.21M	-9.9M	-9.24M	-13.24M	-14.69M	-18.98M	-83.3K
Comprehensive Income	-28K	-74K	-27K	11K	-47K	-4K	-17K	-12K	-14K	-31K	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	1.53M	-10.28M	-11.75M	-14.57M	-8.23M	-1.09M	31.24M	35.02M	37.25M	31.78M	220.94M	216.78M	215.32M	211.02M	-58.3K
Total Investments	n/a	n/a	356K	175K	230K	1.41M	43.21M	42.91M	42.45M	41.68M	230.18M	230.02M	230M	230M	n/a